Trademark: 79303432
Word
DEXPLORER
Status
Registered
Status Code
700
Status Date
Tuesday, March 22, 2022
Serial Number
79303432
Registration Number
6674473
Registration Date
Tuesday, March 22, 2022
Mark Type
3000
Filing Date
Friday, November 27, 2020
Published for Opposition
Tuesday, January 4, 2022

Trademark Owner History
Medicare Pharmaceuticals Inc. - Original Registrant

Classifications
9 Recorded computer software for drug development using artificial intelligence; recorded computer software for analytics for clinical trial data, for data collection, data analysis, data storing, data mining, data generation, and machine learning, all in drug discovery and drug development fields; recorded computer software for simulating drug development; recorded computer software for the analysis of data in the medical and biotechnology fields using algorithm for deep learning; recorded computer software based on artificial intelligence for image analysis and data analysis in the medical and biotechnology fields; recorded computer software for analysing medical diagnostic information; computer operating programs, recorded; recorded computer software for data processing; recorded medical software for pregnancy education; recorded medical software for uploading, storing and submitting medical images for computer-aided diagnosis of respiratory medical conditions affecting humans, providing patient diagnosis risk assessments, workflow management and billing in the field of healthcare; recorded medical software for recording, processing, transmitting, and receiving data for medical diagnostic and monitoring purposes; recorded medical software for aiding in the detection and diagnostics of congestive heart failure; recorded software for artificial intelligence conversion, analysis, processing, storage and transmission
42 Drug discovery services; research for medical products; scientific research and technical consulting on the test, inspection and research of medical products; development of pharmaceutical preparations and medicines; drug discovery services based on artificial intelligence; software design and development; computer software consultancy; application service provider featuring software for local, wide and global communications networks which allow users to connect remote computers and computer networks together to exchange healthcare information and data; software as a service featuring software based on artificial intelligence for the analysis of deep learning image and data in the medical and biotechnology fields; platform as a service featuring computer software platform for data collection, data analysis, data storage and data mining used in the healthcare and biotechnology fields; software as a service featuring software for data collection, data analysis, data storage and data mining used in the healthcare and biotechnology fields; design of computer software for healthcare and medical institutions; installation and maintenance of computer software for healthcare and medical institutions; technical consultation related to medical research, biotechnology data analysis and software development; technical consultation related to medical data analysis for research purposes; technical consultation related to software development in the medical field; research and development of computer software platform in the artificial intelligence field; software development for artificial intelligence service; drug discovery services through computer modeling methods; development of computer software for big data processing
The mark consists of the stylized wording "DEXPLORER" in purple centered above Korean characters in purple.
The color(s) purple is/are claimed as a feature of the mark.
The transliteration of the non-Latin characters in the mark is "Dexplorer" and this has no meaning in a foreign language.

Trademark Events
Sep 5, 2022
Final Decision Transaction Processed By Ib
Aug 12, 2022
Final Disposition Notice Sent To Ib
Aug 11, 2022
Final Disposition Processed
Jun 22, 2022
Final Disposition Notice Created, To Be Sent To Ib
Mar 22, 2022
Registered-Principal Register
Jan 4, 2022
Official Gazette Publication Confirmation E-Mailed
Jan 4, 2022
Published For Opposition
Jan 1, 2022
Notification Processed By Ib
Dec 15, 2021
Notification Of Possible Opposition Sent To Ib
Dec 15, 2021
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Dec 15, 2021
Notification Of Notice Of Publication E-Mailed
Dec 2, 2021
Approved For Pub - Principal Register
Dec 2, 2021
Examiner's Amendment Entered
Dec 2, 2021
Notification Of Examiners Amendment E-Mailed
Dec 2, 2021
Examiners Amendment E-Mailed
Dec 2, 2021
Examiners Amendment -Written
Nov 18, 2021
Teas/Email Correspondence Entered
Nov 18, 2021
Correspondence Received In Law Office
Nov 18, 2021
Teas Response To Office Action Received
Nov 15, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Nov 15, 2021
Teas Change Of Correspondence Received
Nov 15, 2021
Teas Change Of Domestic Representatives Address
Nov 15, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 15, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 15, 2021
Teas Change Of Owner Address Received
Jun 13, 2021
Refusal Processed By Ib
May 27, 2021
Non-Final Action Mailed - Refusal Sent To Ib
May 27, 2021
Refusal Processed By Mpu
May 25, 2021
Non-Final Action (Ib Refusal) Prepared For Review
May 24, 2021
Non-Final Action Written
May 12, 2021
Assigned To Examiner
Feb 12, 2021
Application Filing Receipt Mailed
Feb 8, 2021
New Application Office Supplied Data Entered In Tram
Feb 4, 2021
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24